Regeneron Pharmaceuticals, Inc. Equity-NMS: REGN

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Previous close :$610.64
Open :$610.65
Today's high :$612.99
Today's low :$572
52W low :$572
52W high :$1209.6455
EPS(TTM): :38.32
Shares O/S :107.51 M
Market cap :61.65 B

Compare with Other Stocks

Stocks Price 1D PE Market Cap
Regeneron Pharmaceuticals, Inc. $573.45 -242.17% 16.33 61.65B

Frequently Asked Questions

What is the share price of Regeneron Pharmaceuticals, Inc. today?

Regeneron Pharmaceuticals, Inc. (REGN) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

About Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc. is a fully integrated biotechnology company. The Company invents, develops, manufactures, and commercializes medicines for people with serious diseases. Its products and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases. The Company is accelerating drug development using its proprietary technologies, such as VelociSuite, which produces optimized fully human antibodies and new classes of bispecific antibodies. VelociSuite consists of VelocImmune, VelociGene, VelociMouse, VelociMab, Veloci-Bi, VelociT, VelociHum, and other related technologies. Its marketed products include EYLEA (aflibercept); Dupixent (dupilumab); Libtayo (cemiplimab); Ordspono (odronextamab); Kevzara (sarilumab); Itepekimab; Linvoseltamab, and others.